https://clinicaltrials.gov/ct2/show/NCT03872453?type=Intr&cond=Migraine&lupd_s=02%2F27%2F2019&lupd_d=14
Condition : Migraine
Interventions : Drug: BHV3500 10mg; Drug: BHV3500 20mg; Drug: BHV3500 5mg; Drug: BHV3500 matching placebo; Device: Intranasal Aptar Pharma Unit Dose System
Sponsor : Biohaven Pharmaceuticals, Inc.
Not yet recruiting
Acute Treatment Trial in Adult Subjects With Migraines
NCT03872453
Wed, 13 Mar 2019 12:00:00 EDT
Last Update Posted: 03/13/19 10:21AM